{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T14:44:28Z","timestamp":1788965068309,"version":"build-2803163510"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1016\/j.ijrobp.2006.05.021","type":"journal-article","created":{"date-parts":[[2006,8,3]],"date-time":"2006-08-03T12:29:21Z","timestamp":1154608161000},"page":"818-824","source":"Crossref","is-referenced-by-count":46,"title":["Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-\u03b2 for supratentorial glioblastoma: Results of RTOG 9710"],"prefix":"10.1016","volume":"66","author":[{"given":"Howard","family":"Colman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian A.","family":"Berkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe H.","family":"Maor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morris D.","family":"Groves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Vermeulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana F.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minesh P.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.K. Alfred","family":"Yung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2006.05.021_bib1","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1056\/NEJM198012043032303","article-title":"Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery","volume":"303","author":"Walker","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2006.05.021_bib2","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3171\/jns.1978.49.3.0333","article-title":"Evaluation of BCNU and\/or radiotherapy in the treatment of anaplastic gliomas","volume":"49","author":"Walker","year":"1978","journal-title":"J Neurosurg"},{"key":"10.1016\/j.ijrobp.2006.05.021_bib3","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/0360-3016(79)90553-4","article-title":"An analysis of dose-effect relationship in the radiotherapy of malignant gliomas","volume":"5","author":"Walker","year":"1979","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2006.05.021_bib4","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s11864-000-0073-2","article-title":"Malignant gliomas","volume":"1","author":"Burton","year":"2000","journal-title":"Curr Treat Options Oncol"},{"key":"10.1016\/j.ijrobp.2006.05.021_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/neuonc\/1.1.69","article-title":"Chemotherapy for brain tumors of astrocytic and oligodendroglial lineage: The past decade and where we are heading","volume":"1","author":"Levin","year":"1999","journal-title":"Neuro-oncol"},{"key":"10.1016\/j.ijrobp.2006.05.021_bib6","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0140-6736(02)08091-1","article-title":"Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials","volume":"359","author":"Stewart","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2006.05.021_bib7","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1002\/1097-0142(19930415)71:8<2585::AID-CNCR2820710825>3.0.CO;2-S","article-title":"Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults","volume":"71","author":"Fine","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2006.05.021_bib8","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2006.05.021_bib9","first-page":"1177","article-title":"Update on adjuvant interferon therapy for high-risk melanoma","volume":"16","author":"Agarwala","year":"2002","journal-title":"Oncology (Huntingt)"},{"key":"10.1016\/j.ijrobp.2006.05.021_bib10","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s11912-002-0065-4","article-title":"Interferons as antiangiogenic agents","volume":"4","author":"Lindner","year":"2002","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.ijrobp.2006.05.021_bib11","first-page":"663","article-title":"Interferons as biomodulators of fluoropyrimidines in the treatment of colorectal cancer","volume":"26","author":"Makower","year":"1999","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ijrobp.2006.05.021_bib12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00000421-199604000-00020","article-title":"Recombinant beta-interferon in the treatment of patients with metastatic renal cell carcinoma","volume":"19","author":"Mani","year":"1996","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.05.021_bib13","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0303-8467(02)00046-X","article-title":"Long-term benefits of early and high doses of interferon beta-1a treatment in relapsing-remitting multiple sclerosis","volume":"104","author":"Chofflon","year":"2002","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.ijrobp.2006.05.021_bib14","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1212\/WNL.58.8_suppl_4.S3","article-title":"Mechanisms of action of interferons and glatiramer acetate in multiple sclerosis","volume":"58","author":"Dhib-Jalbut","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ijrobp.2006.05.021_bib15","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1212\/WNL.59.6_suppl_3.S1","article-title":"Key issues in the diagnosis and treatment of multiple sclerosis","volume":"59","author":"O\u2019Connor","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.ijrobp.2006.05.021_bib16","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1200\/JCO.1991.9.11.1945","article-title":"Intravenous recombinant interferon beta in patients with recurrent malignant gliomas: a phase I\/II study","volume":"9","author":"Yung","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2006.05.021_bib17","first-page":"381","article-title":"A phase I trial of a new recombinant human beta-interferon (BG9015) for the treatment of patients with recurrent gliomas","volume":"3","author":"Fine","year":"1997","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2006.05.021_bib18","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/jnci\/85.9.704","article-title":"Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials","volume":"85","author":"Curran","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2006.05.021_bib19","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/0895-4356(88)90025-X","article-title":"Sample size considerations for studies comparing survival curves using historical controls","volume":"41","author":"Dixon","year":"1988","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ijrobp.2006.05.021_bib20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ijrobp.2006.05.021_bib21","first-page":"163","article-title":"Evaluation of survival data and two new rank order statistics arising in its consideration","volume":"50","author":"Mantel","year":"1966","journal-title":"Cancer Chemother Rep"},{"key":"10.1016\/j.ijrobp.2006.05.021_bib22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc B"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301606009473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301606009473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T09:31:18Z","timestamp":1736501478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301606009473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0360301606009473"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2006.05.021","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}